High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study
Objective Pharmacological treatment of non-alcoholic fatty liver disease (NAFLD) is still evolving. Probiotics could be a promising treatment option, but their effectiveness needs to be established. The present study aimed to evaluate the efficacy of a high potency multistrain probiotic in adult pat...
Saved in:
| Main Authors: | Ashim Das, Ajay Duseja, Subrat K Acharya, Manu Mehta, Shruti Chhabra, Satyavati Rana, Siddhartha Dattagupta, Radha K Dhiman, Yogesh K Chawla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-08-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/6/1/e000315.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD
by: Minjuan Ma, et al.
Published: (2019-01-01) -
Effects and mechanisms of liraglutide in ameliorating liver fibrosis in NAFLD mice
by: WANG Renjie, et al.
Published: (2025-04-01) -
Current Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Benny Budiman
Published: (2024-05-01) -
Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
by: Suneth Buddhika Agampodi, et al.
Published: (2022-11-01) -
Association of behavioral factors, liver function and NAFLD: Bayesian Mendelian randomization
by: Lei Pu, et al.
Published: (2025-06-01)